Table 2.
Grading system for CS (Davis et al. 2013)
| A: Distribution and extent of crusting | 1 | Wrists, web spaces, feet only (< 10% Total Body Surface Area) |
| 2 | As “1” + forearm, lower legs, buttocks, trunk (or 10–30% TBSA) | |
| 3 | As “2” + scalp (or > 30% TBSA) | |
| B: Crusting/Shedding | 1 | Mild crusting (< 5mm depth), minimal skin shedding |
| 2 | Moderate (5-10mm) crusting, moderate skin shedding | |
| 3 | Severe (> 10mm), severe skin shedding | |
| C: Past episodes | 1 | No previous episodes |
| 2 | 1–3 hospitalizations for CS (or depigmentation of elbow, knees) | |
| 3 | > 4 previous hospitalizations (or depigmentation as above + legs/back, or residual skin thickening) | |
| D: Skin condition | 1 | No cracking or pyoderma |
| 2 | Multiple pustules or weeping sore or superficial skin cracking | |
| 3 | Deep skin cracking with bleeding, widespread exudates | |
|
Grading: - Grade 1: total score 4–6 - Grade 2: total score 7–9 - Grade 3: total score 10–12 Treatment: - Grade 1: 3 doses of IVM (days 0, 1, 7) - Grade 2: 5 doses of IVM (days 0, 1, 7, 8, 14) - Grade 3: 7 doses of IVM (days 0, 1, 7, 8, 14, 21, 28) | ||